Cancer Therapy
Meisoindigo curtails angiogenic processes in chronic myelogenous leukemia cells
Published in Blood Weekly, February 16th, 2006
"Meisoindigo, an active compound of a Chinese anti-leukemia medicine, has been effectively used in the treatment of CML. Increasing evidences have demonstrated that angiogenesis is an important pathobiologic feature of CML," scientists writing in the journal Leukemia Research report.
"The antiangiogenesis effect of meisoindigo on CML is unknown. In this study, we determined the effects of meisoindigo on the apoptosis, adherence, and differentiation of endothelial cells as well as the secretion of vascular endothelial growth factor (VEGF) by CML cells," wrote...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-02-16)
More Articles from Blood Weekly
- Biomedical Engineering
Mild hypothermia preserves bioartificial liver loaded with freshly isolated liver cells - Blood Banking
Germ-free closed system developed for clinical banking of umbilical cord blood - Blood Transfusion
RhD typing for blood transfusion is not needed in southeast Asian populations - Cryopreservation
Trehalose improves cryopreservation of human embryonic stem cells - Tissue Engineering
Chondrocyte-seeded constructs better than unseeded carrier material for knee defect repair - Adult Stem Cells
Powerful technique for multiplying adult stem cells may aid therapies - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
